PUD - Nursing Case Study

Pathophysiology

• Primary mechanism: Peptic Ulcer Disease (PUD) is primarily caused by an imbalance between gastric mucosal defenses and aggressive factors like gastric acid and pepsin. Helicobacter pylori infection is a critical factor as it disrupts the mucosal barrier and stimulates acid secretion, contributing to ulcer formation.

• Secondary mechanism: The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is another significant contributor. NSAIDs inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis which normally protects the gastric lining, thus increasing vulnerability to acid damage.

• Key complication: If untreated, PUD can lead to complications such as bleeding, perforation, and gastric outlet obstruction, each requiring urgent medical intervention to prevent severe outcomes.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: History of smoking, occasional NSAID use for joint pain

• Current medications: Omeprazole 20 mg daily, occasional ibuprofen

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent upper abdominal pain

• Key symptoms: Burning epigastric pain, nausea, occasional vomiting, recent onset of black tarry stools

• Vital signs: Blood pressure 98/60 mmHg, heart rate 95 bpm, respiratory rate 20 breaths per minute, temperature 37.5°C

Section 1

As the healthcare team proceeds with the initial assessment of the 45-year-old male with suspected Peptic Ulcer Disease (PUD), several key findings emerge. On physical examination, he exhibits tenderness in the epigastric region upon palpation, which aligns with his complaint of burning abdominal pain. His vital signs indicate hypotension with a blood pressure of 98/60 mmHg, suggesting potential intravascular volume depletion. The heart rate is slightly elevated at 95 bpm, which could be a compensatory response to maintain cardiac output in light of the low blood pressure. His respiratory rate remains within the normal range, and his temperature is slightly elevated at 37.5°C, which may indicate an inflammatory process but is not yet concerning for a significant systemic infection.

Laboratory results reveal a hemoglobin level of 10.5 g/dL, notably lower than the normal range, reinforcing the suspicion of gastrointestinal bleeding as a likely complication of his PUD. The presence of black tarry stools, or melena, supports the diagnosis of an upper gastrointestinal bleed, likely secondary to ulcer erosion into a blood vessel. Given his history of NSAID use and smoking, the risk of further ulcer complications is pronounced, necessitating urgent medical intervention. The team must consider the need for endoscopic evaluation to identify the source of bleeding and to possibly intervene therapeutically.

The patient's current condition highlights the importance of addressing both the symptomatology and underlying causes of PUD. Immediate management should focus on stabilizing the patient hemodynamically, which may include initiating intravenous fluids to address the hypotension and potentially transfusing blood products if the anemia is severe. Additionally, discontinuing NSAID use and optimizing his proton pump inhibitor therapy is crucial to promote ulcer healing and prevent further bleeding. The healthcare team must remain vigilant for signs of worsening condition, such as increased abdominal pain, signs of perforation, or continued bleeding, to ensure timely intervention and prevent further complications.

Section 2

As the healthcare team continues to monitor the patient, a change in his status becomes evident, necessitating prompt clinical reasoning and intervention. Over the next hour, the patient's condition deteriorates as indicated by a drop in his blood pressure to 88/55 mmHg, coupled with an increase in heart rate to 110 bpm. These changes suggest worsening hypovolemia, likely due to ongoing gastrointestinal bleeding. The patient also reports an escalation in abdominal pain, now described as sharper and more constant, raising concern for potential ulcer perforation or increased bleeding.

In response to these alarming developments, the team orders an urgent repeat hemoglobin test, which reveals a further decline to 9.2 g/dL. This finding, alongside the hemodynamic instability, prompts the decision to initiate a blood transfusion to address the significant anemia and support perfusion. Concurrently, an urgent endoscopy is arranged to visualize the upper gastrointestinal tract and allow for direct intervention if an actively bleeding vessel is identified. The patient is also started on a high-dose intravenous proton pump inhibitor infusion to reduce gastric acid secretion and stabilize the ulcer site.

During the endoscopic procedure, a large duodenal ulcer with an adherent clot is identified, confirming the source of bleeding. Endoscopic hemostatic techniques, including clipping and thermal coagulation, are successfully applied to control the bleeding. Post-procedure, the patient is transferred to a monitored setting for close observation, with a focus on ensuring hemodynamic stability and monitoring for any signs of recurrent bleeding or perforation. This pivotal intervention highlights the critical role of timely diagnostic and therapeutic endoscopy in the management of complicated PUD. The healthcare team remains vigilant, prepared to escalate care further should additional complications arise.

Section 3

Following the successful endoscopic intervention, the patient is closely monitored in a high-dependency unit to ensure stability and anticipate any further complications. Initially, the patient's vital signs show slight improvement; blood pressure stabilizes at 95/60 mmHg, and heart rate decreases to 100 bpm. However, over the next few hours, the patient begins to exhibit signs of altered mental status, becoming increasingly lethargic and disoriented. A neurological assessment reveals a Glasgow Coma Scale score of 13, indicating mild confusion and reduced responsiveness, warranting further investigation.

To elucidate the cause of these neurological changes, additional laboratory tests are conducted. A comprehensive metabolic panel reveals a drop in serum sodium levels to 128 mmol/L, suggesting dilutional hyponatremia, possibly secondary to aggressive fluid resuscitation and the underlying stress response from gastrointestinal bleeding. Meanwhile, a repeat complete blood count shows a hemoglobin level holding at 9.5 g/dL, indicating that the prior transfusion has temporarily stabilized the anemia.

In response to the emerging hyponatremia, the healthcare team initiates a plan to cautiously correct the sodium imbalance, mindful of the risks associated with rapid correction. Fluid management is adjusted to include hypertonic saline, and the patient's fluid status is carefully monitored with frequent electrolyte assessments. The team also considers the possibility of adrenal insufficiency or other endocrine disorders contributing to the patient's altered mental status, planning further endocrine evaluations as needed. These steps underscore the importance of a multidimensional approach in managing the complexities of peptic ulcer disease with systemic implications, as the team remains proactive in anticipating and addressing potential complications.

Section 4

As the healthcare team continues to closely monitor the patient, a noticeable change in the clinical status emerges approximately 12 hours after the initiation of sodium correction. The patient becomes increasingly agitated, showing signs of restlessness and irritability, a stark contrast to the previously observed lethargy. Vital signs indicate a slight increase in blood pressure to 100/65 mmHg and a further decrease in heart rate to 95 bpm. Neurological reassessment shows an improvement in the Glasgow Coma Scale score to 14, suggesting some recovery in mental status but still not fully alert.

However, the latest laboratory results reveal a worrisome trend. The serum sodium level has increased more rapidly than anticipated, now measuring at 134 mmol/L. This prompts concern about overly aggressive correction, which can lead to central pontine myelinolysis if not addressed in a timely manner. The healthcare team promptly revises the fluid management strategy, opting to slow the rate of hypertonic saline infusion and increase monitoring frequency. Additionally, the patient's urine output is carefully measured and recorded, as the risk of osmotic demyelination syndrome necessitates vigilant observation for any new neurological deficits.

In parallel, the team reassesses other potential causes for the patient's altered mental state, including the possibility of underlying infection or sepsis, given the stress of acute gastrointestinal bleeding. Blood cultures are obtained, and broad-spectrum antibiotics are considered as a precautionary measure while awaiting results. This careful, multidisciplinary approach illustrates the dynamic nature of managing peptic ulcer disease with systemic complications, emphasizing the need for constant reassessment and adaptation to evolving clinical scenarios.

Section 5

Approximately 24 hours after the initial sodium correction, the patient exhibits a new change in status that raises concern among the healthcare team. The patient begins complaining of a severe headache and expresses difficulty in maintaining balance when attempting to sit up. Repeat neurological assessment reveals slight weakness in the right upper extremity and subtle slurring of speech, suggesting new neurological involvement. These symptoms prompt the team to expedite imaging studies, suspecting potential osmotic demyelination syndrome secondary to the rapid sodium correction.

A stat MRI of the brain is performed, revealing hyperintense signals in the pons region on T2-weighted images, consistent with central pontine myelinolysis. The medical team immediately revises the management plan, halting the hypertonic saline and switching to isotonic fluids to stabilize the sodium levels more cautiously. Neurology is consulted to guide further management and monitor neurological function closely. The patient's vital signs show a stabilized blood pressure of 102/68 mmHg and a heart rate of 92 bpm, but the new neurological deficits necessitate urgent intervention to prevent further deterioration.

Meanwhile, the rest of the lab work returns, providing some clarity on the patient's systemic status. Blood cultures have identified the presence of a gram-negative bacillus, leading to a targeted adjustment in antibiotic therapy. This dual focus on managing both the neurological and infectious components illustrates the complexity of the patient's condition. The healthcare team remains vigilant, continuously reevaluating the patient's response to interventions and adjusting the treatment plan to address each new complication as it arises, demonstrating the critical importance of an integrated, multidisciplinary approach in managing complex cases of peptic ulcer disease with systemic complications.